BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Reddy SK, Barbas AS, Marroquin CE, Morse MA, Kuo PC, Clary BM. Resection of noncolorectal nonneuroendocrine liver metastases: a comparative analysis. J Am Coll Surg. 2007;204:372-382. [PMID: 17324770 DOI: 10.1016/j.jamcollsurg.2006.12.019] [Cited by in Crossref: 72] [Cited by in F6Publishing: 64] [Article Influence: 4.8] [Reference Citation Analysis]
Number Citing Articles
1 Vassos N, Agaimy A, Hohenberger W, Croner RS. Management of liver metastases of gastrointestinal stromal tumors (GIST). Annals of Hepatology 2015;14:531-9. [DOI: 10.1016/s1665-2681(19)31175-5] [Cited by in Crossref: 18] [Article Influence: 2.6] [Reference Citation Analysis]
2 Labgaa I, Slankamenac K, Schadde E, Jibara G, Alshebeeb K, Mentha G, Clavien P, Schwartz M. Liver resection for metastases not of colorectal, neuroendocrine, sarcomatous, or ovarian (NCNSO) origin: A multicentric study. The American Journal of Surgery 2018;215:125-30. [DOI: 10.1016/j.amjsurg.2017.09.030] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
3 Machairas N, Daskalakis K, Felekouras E, Alexandraki KI, Kaltsas G, Sotiropoulos GC. Currently available treatment options for neuroendocrine liver metastases. Ann Gastroenterol 2021;34:130-41. [PMID: 33654350 DOI: 10.20524/aog.2021.0574] [Reference Citation Analysis]
4 Yuan ZY, Meng MB, Liu CL, Wang HH, Jiang C, Song YC, Zhuang HQ, Yang D, Wang JS, Wei W, Li FT, Zhao LJ, Wang P. Stereotactic body radiation therapy using the CyberKnife(®) system for patients with liver metastases. Onco Targets Ther 2014;7:915-23. [PMID: 24959080 DOI: 10.2147/OTT.S58409] [Cited by in Crossref: 23] [Cited by in F6Publishing: 9] [Article Influence: 2.9] [Reference Citation Analysis]
5 Lok HT, Fung AKY, Chong CCN, Lee KF, Wong J, Cheung SYS, Lai PBS, Ng KKC. Comparison of long-term survival outcome after curative hepatectomy between selected patients with non-colorectal and colorectal liver metastasis: A propensity score matching analysis. Asian J Surg 2021;44:459-64. [PMID: 33229125 DOI: 10.1016/j.asjsur.2020.10.019] [Reference Citation Analysis]
6 Howlader M, Heaton N, Rela M. Resection of liver metastases from breast cancer: Towards a management guideline. International Journal of Surgery 2011;9:285-91. [DOI: 10.1016/j.ijsu.2011.01.009] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 2.4] [Reference Citation Analysis]
7 Chua TC, Saxena A, Liauw W, Chu F, Morris DL. Hepatic resection for metastatic breast cancer: a systematic review. Eur J Cancer. 2011;47:2282-2290. [PMID: 21741832 DOI: 10.1016/j.ejca.2011.06.024] [Cited by in Crossref: 66] [Cited by in F6Publishing: 60] [Article Influence: 6.0] [Reference Citation Analysis]
8 Høyer M, Swaminath A, Bydder S, Lock M, Méndez Romero A, Kavanagh B, Goodman KA, Okunieff P, Dawson LA. Radiotherapy for liver metastases: a review of evidence. Int J Radiat Oncol Biol Phys. 2012;82:1047-1057. [PMID: 22284028 DOI: 10.1016/j.ijrobp.2011.07.020] [Cited by in Crossref: 133] [Cited by in F6Publishing: 109] [Article Influence: 13.3] [Reference Citation Analysis]
9 Negoi I, Runcanu A, Paun S, Negoi RI, Beuran M. Resection of Large Metachronous Liver Metastasis with Gastric Origin: Case Report and Review of the Literature. Cureus 2016;8:e814. [PMID: 27843732 DOI: 10.7759/cureus.814] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
10 Martel G, Hawel J, Rekman J, Croome KP, Bertens K, Balaa FK, Hernandez-Alejandro R. Liver resection for non-colorectal, non-carcinoid, non-sarcoma metastases: a multicenter study. PLoS One 2015;10:e0120569. [PMID: 25811923 DOI: 10.1371/journal.pone.0120569] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 2.4] [Reference Citation Analysis]
11 Lendoire J, Moro M, Andriani O, Grondona J, Gil O, Raffin G, Silva J, Bracco R, Podestá G, Valenzuela C. Liver resection for non-colorectal, non-neuroendocrine metastases: analysis of a multicenter study from Argentina. HPB (Oxford). 2007;9:435-439. [PMID: 18345290 DOI: 10.1080/13651820701769701] [Cited by in Crossref: 44] [Cited by in F6Publishing: 39] [Article Influence: 3.7] [Reference Citation Analysis]
12 Holzner PA, Makowiec F, Klock A, Glatz T, Fichtner-Feigl S, Lang SA, Neeff HP. Outcome after hepatic resection for isolated non-colorectal, non-neuroendocrine liver metastases in 100 patients - the role of the embryologic origin of the primary tumor. BMC Surg 2018;18:89. [PMID: 30373582 DOI: 10.1186/s12893-018-0424-1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
13 Abbott DE, Brouquet A, Mittendorf EA, Andreou A, Meric-Bernstam F, Valero V, Green MC, Kuerer HM, Curley SA, Abdalla EK. Resection of liver metastases from breast cancer: estrogen receptor status and response to chemotherapy before metastasectomy define outcome. Surgery. 2012;151:710-716. [PMID: 22285778 DOI: 10.1016/j.surg.2011.12.017] [Cited by in Crossref: 76] [Cited by in F6Publishing: 66] [Article Influence: 7.6] [Reference Citation Analysis]
14 Tapia Rico G, Townsend AR, Klevansky M, Price TJ. Liver metastases resection for gastric and esophageal tumors: is there enough evidence to go down this path? Expert Rev Anticancer Ther. 2016;16:1219-1225. [PMID: 27744727 DOI: 10.1080/14737140.2016.1249858] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
15 Costa SRP, Horta SH, Henriques AC, Waisberg J, Speranzini MB. Hepatectomia para o tratamento de metástases colorretais e não-colorretais: análise comparativa em 30 casos operados. Rev bras colo-proctol 2009;29:216-25. [DOI: 10.1590/s0101-98802009000200009] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
16 Rashidian N, Alseidi A, Kirks RC. Cancers Metastatic to the Liver. Surg Clin North Am 2020;100:551-63. [PMID: 32402300 DOI: 10.1016/j.suc.2020.02.005] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
17 Saxena A, Chua TC, Perera M, Chu F, Morris DL. Surgical resection of hepatic metastases from neuroendocrine neoplasms: a systematic review. Surg Oncol 2012;21:e131-41. [PMID: 22658833 DOI: 10.1016/j.suronc.2012.05.001] [Cited by in Crossref: 73] [Cited by in F6Publishing: 68] [Article Influence: 7.3] [Reference Citation Analysis]
18 Schiergens TS, Lüning J, Renz BW, Thomas M, Pratschke S, Feng H, Lee SM, Engel J, Rentsch M, Guba M. Liver Resection for Non-colorectal Non-neuroendocrine Metastases: Where Do We Stand Today Compared to Colorectal Cancer? J Gastrointest Surg. 2016;20:1163-1172. [PMID: 26921025 DOI: 10.1007/s11605-016-3115-1] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.7] [Reference Citation Analysis]
19 Kamel SI, de Jong MC, Schulick RD, Diaz-Montes TP, Wolfgang CL, Hirose K, Edil BH, Choti MA, Anders RA, Pawlik TM. The role of liver-directed surgery in patients with hepatic metastasis from a gynecologic primary carcinoma. World J Surg. 2011;35:1345-1354. [PMID: 21452068 DOI: 10.1007/s00268-011-1074-y] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 1.1] [Reference Citation Analysis]
20 Clarke NAR, Kanhere HA, Trochsler MI, Maddern GJ. Liver resection for non-colorectal non-neuroendocrine metastases. ANZ J Surg. 2018;88:E313-E317. [PMID: 27490345 DOI: 10.1111/ans.13700] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
21 Lee SY, Cheow PC, Teo JY, Ooi LL. Surgical treatment of neuroendocrine liver metastases. Int J Hepatol 2012;2012:146590. [PMID: 22319650 DOI: 10.1155/2012/146590] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
22 Guner A, Son T, Cho I, Kwon IG, An JY, Kim HI, Cheong JH, Noh SH, Hyung WJ. Liver-directed treatments for liver metastasis from gastric adenocarcinoma: comparison between liver resection and radiofrequency ablation. Gastric Cancer. 2016;19:951-960. [PMID: 26231353 DOI: 10.1007/s10120-015-0522-z] [Cited by in Crossref: 30] [Cited by in F6Publishing: 35] [Article Influence: 4.3] [Reference Citation Analysis]
23 Ichida H, Imamura H, Yoshimoto J, Sugo H, Kajiyama Y, Tsurumaru M, Suzuki K, Ishizaki Y, Kawasaki S. Pattern of Postoperative Recurrence and Hepatic and/or Pulmonary Resection for Liver and/or Lung Metastases From Esophageal Carcinoma. World J Surg 2013;37:398-407. [DOI: 10.1007/s00268-012-1830-7] [Cited by in Crossref: 36] [Cited by in F6Publishing: 30] [Article Influence: 3.6] [Reference Citation Analysis]
24 Bergenfeldt M, Jensen BV, Skjoldbye B, Nielsen D. Liver resection and local ablation of breast cancer liver metastases--a systematic review. Eur J Surg Oncol. 2011;37:549-557. [PMID: 21605957 DOI: 10.1016/j.ejso.2011.04.013] [Cited by in Crossref: 37] [Cited by in F6Publishing: 34] [Article Influence: 3.4] [Reference Citation Analysis]
25 Ercolani G, Zanello M, Serenari M, Cescon M, Cucchetti A, Ravaioli M, Del Gaudio M, D'Errico A, Brandi G, Pinna AD. Ten-Year Survival after Liver Resection for Breast Metastases: A Single-Center Experience. Dig Surg 2018;35:372-80. [PMID: 29393171 DOI: 10.1159/000486523] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
26 Bhutiani N, Bruenderman EH, Jones JM, Wehry JH, Egger ME, Philips P, Scoggins CR, McMasters KM, Martin RCG. A literature-based treatment algorithm for low-grade neuroendocrine liver metastases. HPB (Oxford) 2021;23:63-70. [PMID: 32448647 DOI: 10.1016/j.hpb.2020.04.012] [Reference Citation Analysis]
27 Veltri A, Gazzera C, Barrera M, Busso M, Solitro F, Filippini C, Garetto I. Radiofrequency thermal ablation (RFA) of hepatic metastases (METS) from breast cancer (BC): an adjunctive tool in the multimodal treatment of advanced disease. Radiol Med. 2014;119:327-333. [PMID: 24297589 DOI: 10.1007/s11547-013-0354-z] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
28 Andreou A, Brouquet A, Bharathy KG, Perrier ND, Abdalla EK, Curley SA, Glanemann M, Seehofer D, Neuhaus P, Vauthey JN, Aloia TA. Liver resection for liver metastases from nondigestive endocrine cancer: extrahepatic disease burden defines outcome. Surgery 2012;151:851-9. [PMID: 22306838 DOI: 10.1016/j.surg.2011.12.025] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
29 Sim DPY, Goh BKP, Lee SY, Chan CY, Tan IBH, Cheow PC, Jeyaraj P, Chow PKH, Ooi LLPJ, Chung AYF. Preoperative Prognostic Factors After Liver Resection for Non-Colorectal, Non-Neuroendocrine Liver Metastases and Validation of the Adam Score in an Asian Population. World J Surg 2018;42:1073-84. [PMID: 28875334 DOI: 10.1007/s00268-017-4208-z] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
30 Charalampoudis P, Mantas D, Sotiropoulos GC, Dimitroulis D, Kouraklis G, Markopoulos C. Surgery for liver metastases from breast cancer. Future Oncol. 2015;11:1519-1530. [PMID: 25963429 DOI: 10.2217/fon.15.43] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
31 Sun MS, Liu HJ, Yun YY, Yu ZH, Yang F, Liu YH, Xu L. Survival Benefit of Surgical Treatment Added Into Systemic Treatment for Isolated Breast Cancer Liver Metastases: A Systematic Review and Meta-Analysis. Front Surg 2021;8:751906. [PMID: 34760920 DOI: 10.3389/fsurg.2021.751906] [Reference Citation Analysis]
32 Sterzing F, Brunner TB, Ernst I, Baus WW, Greve B, Herfarth K, Guckenberger M. Stereotactic body radiotherapy for liver tumors: Principles and practical guidelines of the DEGRO Working Group on Stereotactic Radiotherapy. Strahlenther Onkol 2014;190:872-81. [DOI: 10.1007/s00066-014-0714-1] [Cited by in Crossref: 66] [Cited by in F6Publishing: 58] [Article Influence: 8.3] [Reference Citation Analysis]
33 Ripley RT, Davis JL, Klapper JA, Mathur A, Kammula U, Royal RE, Yang JC, Sherry RM, Hughes MS, Libutti SK. Liver resection for metastatic melanoma with postoperative tumor-infiltrating lymphocyte therapy. Ann Surg Oncol. 2010;17:163-170. [PMID: 19777192 DOI: 10.1245/s10434-009-0677-0] [Cited by in Crossref: 19] [Cited by in F6Publishing: 13] [Article Influence: 1.5] [Reference Citation Analysis]
34 Zacherl M, Bernhardt GA, Zacherl J, Gruber G, Kornprat P, Bacher H, Mischinger HJ, Windhager R, Jakesz R, Grünberger T. Surgery for liver metastases originating from sarcoma-case series. Langenbecks Arch Surg 2011;396:1083-91. [PMID: 21739304 DOI: 10.1007/s00423-011-0821-8] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
35 Shubert CR, Habermann EB, Truty MJ, Thomsen KM, Kendrick ML, Nagorney DM. Defining Perioperative Risk after Hepatectomy Based on Diagnosis and Extent of Resection. J Gastrointest Surg 2014;18:1917-28. [DOI: 10.1007/s11605-014-2634-x] [Cited by in Crossref: 31] [Cited by in F6Publishing: 23] [Article Influence: 3.9] [Reference Citation Analysis]
36 Hoffmann K, Bulut S, Tekbas A, Hinz U, Büchler MW, Schemmer P. Is Hepatic Resection for Non-colorectal, Non-neuroendocrine Liver Metastases Justified? Ann Surg Oncol. 2015;22 Suppl 3:S1083-S1092. [PMID: 26242369 DOI: 10.1245/s10434-015-4775-x] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 3.6] [Reference Citation Analysis]
37 Parisi A, Trastulli S, Ricci F, Regina R, Cirocchi R, Grassi V, Gemini A, Pironi D, D'andrea V, Santoro A, Desiderio J. Analysis of long-term results after liver surgery for metastases from colorectal and non-colorectal tumors: A retrospective cohort study. International Journal of Surgery 2016;30:25-30. [DOI: 10.1016/j.ijsu.2016.04.004] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
38 Fitzgerald TL, Brinkley J, Banks S, Vohra N, Englert ZP, Zervos EE. The benefits of liver resection for non-colorectal, non-neuroendocrine liver metastases: a systematic review. Langenbecks Arch Surg. 2014;399:989-1000. [PMID: 25148767 DOI: 10.1007/s00423-014-1241-3] [Cited by in Crossref: 35] [Cited by in F6Publishing: 33] [Article Influence: 4.4] [Reference Citation Analysis]
39 Weinrich M, Weiß C, Schuld J, Rau BM. Liver resections of isolated liver metastasis in breast cancer: results and possible prognostic factors. HPB Surg 2014;2014:893829. [PMID: 24550602 DOI: 10.1155/2014/893829] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 2.9] [Reference Citation Analysis]
40 Lee RC, Kanhere H, Trochsler M, Broadbridge V, Maddern G, Price TJ. Pancreatic, periampullary and biliary cancer with liver metastases: Should we consider resection in selected cases? World J Gastrointest Oncol 2018; 10(8): 211-220 [PMID: 30147847 DOI: 10.4251/wjgo.v10.i8.211] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
41 Ramia JM, García-Bracamonte B, de la Plaza R, Ortiz P, García-Parreño J, Vanaclocha F. [Surgical treatment of melanoma liver metastases]. Cir Esp 2013;91:4-8. [PMID: 23219418 DOI: 10.1016/j.ciresp.2012.10.002] [Reference Citation Analysis]
42 Bacchetti S, Pasqual EM, Bertozzi S, Londero AP, Risaliti A. Curative versus palliative surgical resection of liver metastases in patients with neuroendocrine tumors: a meta-analysis of observational studies. Gland Surg. 2014;3:243-251. [PMID: 25493256 DOI: 10.3978/j.issn.2227-684x.2014.02.05] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
43 Schmelzle M, Eisenberger CF, am Esch JS 2nd, Matthaei H, Krausch M, Knoefel WT. Non-colorectal, non-neuroendocrine, and non-sarcoma metastases of the liver: resection as a promising tool in the palliative management. Langenbecks Arch Surg 2010;395:227-34. [PMID: 19998042 DOI: 10.1007/s00423-009-0580-y] [Cited by in Crossref: 22] [Cited by in F6Publishing: 15] [Article Influence: 1.7] [Reference Citation Analysis]
44 Fairhurst K, Leopardi L, Satyadas T, Maddern G. The safety and effectiveness of liver resection for breast cancer liver metastases: A systematic review. Breast 2016;30:175-84. [PMID: 27764727 DOI: 10.1016/j.breast.2016.09.011] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
45 Staehler MD, Kruse J, Haseke N, Stadler T, Roosen A, Karl A, Stief CG, Jauch KW, Bruns CJ. Liver resection for metastatic disease prolongs survival in renal cell carcinoma: 12-year results from a retrospective comparative analysis. World J Urol. 2010;28:543-547. [PMID: 20440505 DOI: 10.1007/s00345-010-0560-4] [Cited by in Crossref: 92] [Cited by in F6Publishing: 71] [Article Influence: 7.7] [Reference Citation Analysis]
46 Maeda Y, Shinohara T, Katayama T, Futakawa N, Hamada T. Hepatectomy for liver metastases in non-colorectal, non-neuroendocrine cancer patients. The survival benefit in primary unresectable cases. Int J Surg 2015;22:136-42. [PMID: 26277530 DOI: 10.1016/j.ijsu.2015.07.716] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
47 Groeschl RT, Nachmany I, Steel JL, Reddy SK, Glazer ES, de Jong MC, Pawlik TM, Geller DA, Tsung A, Marsh JW, Clary BM, Curley SA, Gamblin TC. Hepatectomy for Noncolorectal Non-Neuroendocrine Metastatic Cancer: A Multi-Institutional Analysis. Journal of the American College of Surgeons 2012;214:769-77. [DOI: 10.1016/j.jamcollsurg.2011.12.048] [Cited by in Crossref: 87] [Cited by in F6Publishing: 78] [Article Influence: 8.7] [Reference Citation Analysis]
48 Liao Y, Fan X, Wang X. Effects of different metastasis patterns, surgery and other factors on the prognosis of patients with stage IV non-small cell lung cancer: A Surveillance, Epidemiology, and End Results (SEER) linked database analysis. Oncol Lett 2019;18:581-92. [PMID: 31289530 DOI: 10.3892/ol.2019.10373] [Cited by in Crossref: 2] [Cited by in F6Publishing: 10] [Article Influence: 0.7] [Reference Citation Analysis]
49 Aubin J, Rekman J, Vandenbroucke-menu F, Lapointe R, Fairfull-smith RJ, Mimeault R, Balaa FK, Martel G. Systematic review and meta-analysis of liver resection for metastatic melanoma. British Journal of Surgery 2013;100:1138-47. [DOI: 10.1002/bjs.9189] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 2.9] [Reference Citation Analysis]
50 Lo SS, Moffatt-bruce SD, Dawson LA, Schwarz RE, Teh BS, Mayr NA, Lu JJ, Grecula JC, Olencki TE, Timmerman RD. The role of local therapy in the management of lung and liver oligometastases. Nat Rev Clin Oncol 2011;8:405-16. [DOI: 10.1038/nrclinonc.2011.75] [Cited by in Crossref: 79] [Cited by in F6Publishing: 84] [Article Influence: 7.2] [Reference Citation Analysis]
51 Kalil AN, Trindade EN, Torres SL, Kalil F, Coltro D, Remonti T. Liver Resection for Noncolorectal, Nonneuroendocrine Metastases: A Single-center Experience. The American Surgeon 2013;79:323-4. [DOI: 10.1177/000313481307900335] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
52 Motoyama H, Kobayashi A, Yokoyama T, Shimizu A, Kitagawa N, Notake T, Fukushima K, Masuo H, Yoshizawa T, Miyagawa S. Survival Benefits of Surgical Resection in Patients with Recurrent Biliary Tract Carcinoma. World J Surg 2017;41:2817-29. [DOI: 10.1007/s00268-017-4107-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
53 Hameed AM, Ng EI, Johnston E, Hollands MJ, Richardson AJ, Pleass HC, Lam VW. Hepatic resection for metastatic melanoma: a systematic review. Melanoma Research 2014;24:1-10. [DOI: 10.1097/cmr.0000000000000032] [Cited by in Crossref: 8] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
54 Tan MC, Jarnagin WR. Surgical management of non-colorectal hepatic metastasis: Non-Colorectal Metastatectomy. J Surg Oncol 2014;109:8-13. [DOI: 10.1002/jso.23462] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
55 Mullinax JE, Zager JS, Gonzalez RJ. Current diagnosis and management of retroperitoneal sarcoma. Cancer Control. 2011;18:177-187. [PMID: 21666580 DOI: 10.1177/107327481101800305] [Cited by in Crossref: 48] [Cited by in F6Publishing: 36] [Article Influence: 4.4] [Reference Citation Analysis]
56 Reddy SK, Clary BM. Neuroendocrine liver metastases. Surg Clin North Am. 2010;90:853-861. [PMID: 20637952 DOI: 10.1016/j.suc.2010.04.016] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 2.3] [Reference Citation Analysis]
57 Sadot E, Lee SY, Sofocleous CT, Solomon SB, Gönen M, Peter Kingham T, Allen PJ, DeMatteo RP, Jarnagin WR, Hudis CA. Hepatic Resection or Ablation for Isolated Breast Cancer Liver Metastasis: A Case-control Study With Comparison to Medically Treated Patients. Ann Surg. 2016;264:147-154. [PMID: 26445472 DOI: 10.1097/sla.0000000000001371] [Cited by in Crossref: 45] [Cited by in F6Publishing: 20] [Article Influence: 9.0] [Reference Citation Analysis]
58 de Ridder J, van Walsum M, Verhoef C, Nagtegaal I, de Wilt J. Hepatic resection for metastatic melanoma in The Netherlands: survival and prognostic factors. Melanoma Research 2013;23:27-32. [DOI: 10.1097/cmr.0b013e32835b70c8] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
59 Huang F, Wu G, Yang K. Oligometastasis and oligo-recurrence: more than a mirage. Radiat Oncol 2014;9:230. [PMID: 25359216 DOI: 10.1186/s13014-014-0230-6] [Cited by in Crossref: 37] [Cited by in F6Publishing: 38] [Article Influence: 4.6] [Reference Citation Analysis]
60 Kassahun WT. Controversies in defining prognostic relevant selection criteria that determine long-term effectiveness of liver resection for noncolorectal nonneuroendocrine liver metastasis. International Journal of Surgery 2015;24:85-90. [DOI: 10.1016/j.ijsu.2015.11.002] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
61 Bresadola V, Rossetto A, Adani GL, Baccarani U, Lorenzin D, Favero A, Bresadola F. Liver resection for noncolorectal and nonneuroendocrine metastases: Results of a study on 56 patients at a single institution. Tumori 2011;97:316-22. [DOI: 10.1177/030089161109700310] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
62 Leblanc F, Fonck M, Brunet R, Becouarn Y, Mathoulin-Pélissier S, Evrard S. Comparison of hepatic recurrences after resection or intraoperative radiofrequency ablation indicated by size and topographical characteristics of the metastases. Eur J Surg Oncol. 2008;34:185-190. [PMID: 17998155 DOI: 10.1016/j.ejso.2007.09.028] [Cited by in Crossref: 26] [Cited by in F6Publishing: 29] [Article Influence: 1.7] [Reference Citation Analysis]
63 Marudanayagam R, Sandhu B, Perera MT, Taniere P, Coldham C, Bramhall S, Mayer D, Buckels J, Mirza D. Hepatic resection for non-colorectal, non-neuroendocrine, non-sarcoma metastasis: a single-centre experience. HPB (Oxford) 2011;13:286-92. [PMID: 21418135 DOI: 10.1111/j.1477-2574.2010.00285.x] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 1.8] [Reference Citation Analysis]
64 Kennedy AS, Dezarn WA, McNeillie P, Coldwell D, Nutting C, Carter D, Murthy R, Rose S, Warner RR, Liu D, Palmedo H, Overton C, Jones B, Salem R. Radioembolization for unresectable neuroendocrine hepatic metastases using resin 90Y-microspheres: early results in 148 patients. Am J Clin Oncol. 2008;31:271-279. [PMID: 18525307 DOI: 10.1097/coc.0b013e31815e4557] [Cited by in Crossref: 276] [Cited by in F6Publishing: 100] [Article Influence: 19.7] [Reference Citation Analysis]
65 Goody RB, Brade AM, Wang L, Craig T, Brierley J, Dinniwell R, Wong RKS, Cho C, Kim J, Kassam Z, Ringash J, Knox JJ, Dawson LA. Phase I trial of radiation therapy and sorafenib in unresectable liver metastases. Radiother Oncol 2017;123:234-9. [PMID: 28202227 DOI: 10.1016/j.radonc.2017.01.018] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
66 Schefter TE, Kavanagh BD. Radiation therapy for liver metastases. Semin Radiat Oncol. 2011;21:264-270. [PMID: 21939855 DOI: 10.1016/j.semradonc.2011.05.006] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 2.7] [Reference Citation Analysis]
67 Ramacciato G, D'angelo F, Baldini R, Petrucciani N, Antolino L, Aurello P, Nigri G, Bellagamba R, Pezzoli F, Balesh A, Cucchetti A, Cescon M, Gaudio MD, Ravaioli M, Pinna AD. Hepatocellular Carcinomas and Primary Liver Tumors as Predictive Factors for Postoperative Mortality after Liver Resection: A Meta-Analysis of More than 35,000 Hepatic Resections. The American Surgeon 2012;78:456-67. [DOI: 10.1177/000313481207800438] [Cited by in Crossref: 17] [Cited by in F6Publishing: 9] [Article Influence: 1.7] [Reference Citation Analysis]